Source:http://linkedlifedata.com/resource/pubmed/id/20219919
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2010-4-22
|
pubmed:abstractText |
APOBEC3G (A3G) is a host cytidine deaminase that serves as a potent intrinsic inhibitor of retroviral replication. A3G is packaged into human immunodeficiency virus type 1 virions and deaminates deoxycytidine to deoxyuridine on nascent minus-strand retroviral cDNA, leading to hyper-deoxyguanine-to-deoxyadenine mutations on positive-strand cDNA and inhibition of viral replication. The antiviral activity of A3G is suppressed by Vif, a lentiviral accessory protein that prevents encapsidation of A3G. In this study, we identified dominant negative mutants of Vif that interfered with the ability of wild-type Vif to inhibit the encapsidation and antiviral activity of A3G. These mutants were nonfunctional due to mutations in the highly conserved HCCH and/or SOCS box motifs, which are required for assembly of a functional Cul5-E3 ubiquitin ligase complex. Similarly, mutation or deletion of a PPLP motif, which was previously reported to be important for Vif dimerization, induced a dominant negative phenotype. Expression of dominant negative Vif counteracted the Vif-induced reduction of intracellular A3G levels, presumably by preventing Vif-induced A3G degradation. Consequently, dominant negative Vif interfered with wild-type Vif's ability to exclude A3G from viral particles and reduced viral infectivity despite the presence of wild-type Vif. The identification of dominant negative mutants of Vif presents exciting possibilities for the design of novel antiviral strategies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/APOBEC3G protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cytidine Deaminase,
http://linkedlifedata.com/resource/pubmed/chemical/Mutant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Virulence Factors,
http://linkedlifedata.com/resource/pubmed/chemical/vif Gene Products, Human...,
http://linkedlifedata.com/resource/pubmed/chemical/vif protein, Human...
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1098-5514
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
84
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5201-11
|
pubmed:dateRevised |
2010-11-2
|
pubmed:meshHeading |
pubmed-meshheading:20219919-Cell Line,
pubmed-meshheading:20219919-Cytidine Deaminase,
pubmed-meshheading:20219919-HIV-1,
pubmed-meshheading:20219919-Humans,
pubmed-meshheading:20219919-Microbial Viability,
pubmed-meshheading:20219919-Mutant Proteins,
pubmed-meshheading:20219919-Mutation,
pubmed-meshheading:20219919-Virulence Factors,
pubmed-meshheading:20219919-vif Gene Products, Human Immunodeficiency Virus
|
pubmed:year |
2010
|
pubmed:articleTitle |
Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded Vif.
|
pubmed:affiliation |
Laboratory of Microbiology, Viral Biochemistry Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-0460, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Intramural
|